Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1478-6362
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients ; volume:24 ; number:1 ; day:29 ; month:4 ; year:2022 ; pages:1-11 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (29.4.2022), 1-11, 12.2022

Urheber
Zanin-Silva, Djúlio C.
Santana-Gonçalves, Maynara
Kawashima-Vasconcelos, Marianna Y.
Lima-Júnior, João R.
Dias, Juliana B. E.
Moraes, Daniela A.
Covas, Dimas T.
Malmegrim, Kelen C. R.
Ramalho, Leandra
Oliveira, Maria Carolina
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13075-022-02779-w
URN
urn:nbn:de:101:1-2022071006492530313994
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:19 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Zanin-Silva, Djúlio C.
  • Santana-Gonçalves, Maynara
  • Kawashima-Vasconcelos, Marianna Y.
  • Lima-Júnior, João R.
  • Dias, Juliana B. E.
  • Moraes, Daniela A.
  • Covas, Dimas T.
  • Malmegrim, Kelen C. R.
  • Ramalho, Leandra
  • Oliveira, Maria Carolina
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients

Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis

Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab

Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab

Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis

Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis

Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis

Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation

Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients

Bedeutung von Rac1 und connective tissue growth factor für strukturelles Remodeling bei Vorhofflimmern

Hochschulschrift

Bedeutung von Rac1 und connective tissue growth factor für strukturelles Remodeling bei Vorhofflimmern

Verbundene Objekte